v3.25.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]      
Revenues
Operating expenses      
Sales and marketing expenses (716,264) (1,771,614) (2,051,550)
General and administrative expenses (1,838,740) (1,657,879) (1,315,509)
Research and development expenses (832,565) (1,459,828) (929,916)
Total operating expenses (3,387,569) (4,889,321) (4,296,975)
Loss from operations (3,387,569) (4,889,321) (4,296,975)
Other income (expense)      
Other income, net 24,644 33,678
Interest income 82,268 12,743 66
Interest expense (95,753) (22,428)
Total other income (expense), net 11,159 (9,685) 33,744
Loss before income taxes (3,376,410) (4,899,006) (4,263,231)
Income tax expense
Net loss (3,376,410) (4,899,006) (4,263,231)
Other comprehensive (loss) income      
Foreign currency translation adjustment (23,847) 1,111 18,750
Comprehensive loss $ (3,400,257) $ (4,897,895) $ (4,244,481)
Weighted average number of ordinary shares outstanding*      
Weighted average number of ordinary shares outstanding Basic 6,080,847 [1] 4,500,000 [2] 4,500,000 [2]
Weighted average number of ordinary shares outstanding Diluted 6,080,847 [1] 4,500,000 [2] 4,500,000 [2]
Loss per share*      
Loss per share Basic [2] $ (0.54) $ (1.09) $ (0.95)
Loss per share Diluted [2] $ (0.54) $ (1.09) $ (0.95)
[1] Excluding 450,000 holdback shares subject to surrender and forfeiture.
[2] Retroactively restated to reflect the reverse recapitalization as described in Note 4.